pyrazines has been researched along with Familial Combined Hyperlipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelin, B; Berglund, L; Ericsson, S; Eriksson, M | 1 |
| Angelin, B; Ericsson, S; Eriksson, M | 1 |
2 other study(ies) available for pyrazines and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy.
Topics: Adult; Aged; Aged, 80 and over; Apolipoproteins B; Cholesterol, HDL; Cholesterol, VLDL; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Phenotype; Pyrazines; Triglycerides | 1992 |
Biliary lipids in familial combined hyperlipidaemia: effects of acipimox therapy.
Topics: Adult; Aged; Bile; Cholelithiasis; Cholesterol; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipid Metabolism; Male; Middle Aged; Pyrazines | 1990 |